Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

160 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. Poser CM, et al. Among authors: davis fa. Ann Neurol. 1983 Mar;13(3):227-31. doi: 10.1002/ana.410130302. Ann Neurol. 1983. PMID: 6847134 No abstract available.
Movement phosphenes in optic neuritis: a new clinical sign.
Davis FA, Bergen D, Schauf C, McDonald I, Deutsch W. Davis FA, et al. Neurology. 1976 Nov;26(11):1100-4. doi: 10.1212/wnl.26.11.1100. Neurology. 1976. PMID: 988518
Patient selection and criteria.
Paty DW, Davis FA. Paty DW, et al. Among authors: davis fa. Arch Neurol. 1983 Oct 21;40(11):701. doi: 10.1001/archneur.1983.04050100041015. Arch Neurol. 1983. PMID: 6625979 No abstract available.
Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis.
Stefoski D, Schauf CL, McLeod BC, Haywood CP, Davis FA. Stefoski D, et al. Among authors: davis fa. Neurology. 1982 Aug;32(8):904-7. doi: 10.1212/wnl.32.8.904. Neurology. 1982. PMID: 7201588
Mechanical fragility of erythrocytes in multiple sclerosis.
Schauf CL, Frischer H, Davis FA. Schauf CL, et al. Among authors: davis fa. Neurology. 1980 Mar;30(3):323-5. doi: 10.1212/wnl.30.3.323. Neurology. 1980. PMID: 7189035
Physiologic basis for neuroelectric blocking activity in multiple sclerosis.
Schauf CL, Pencek TL, Davis FA, Rooney MW. Schauf CL, et al. Among authors: davis fa. Neurology. 1981 Oct;31(10):1337-41. doi: 10.1212/wnl.31.10.1338. Neurology. 1981. PMID: 6287352 No abstract available.
Neuroelectric blocking activity and plasmapheresis in amyotrophic lateral sclerosis.
Schauf CL, Antel JP, Arnason BG, Davis FA, Rooney MW. Schauf CL, et al. Among authors: davis fa. Neurology. 1980 Sep;30(9):1011-3. doi: 10.1212/wnl.30.9.1011. Neurology. 1980. PMID: 6252513
4-Aminopyridine in multiple sclerosis: prolonged administration.
Stefoski D, Davis FA, Fitzsimmons WE, Luskin SS, Rush J, Parkhurst GW. Stefoski D, et al. Among authors: davis fa. Neurology. 1991 Sep;41(9):1344-8. doi: 10.1212/wnl.41.9.1344. Neurology. 1991. PMID: 1891078 Clinical Trial.
Neural blocking activity of multiple sclerosis and EAE sera.
Davis FA, Schauf CL. Davis FA, et al. Neurology. 1976 Jun;26(6 PT 2):43-4. doi: 10.1212/wnl.26.6_part_2.43. Neurology. 1976. PMID: 1083963 No abstract available.
The occurrence, specificity, and role of neuroelectric blocking factors in multiple sclerosis.
Schauf CL, Davis FA. Schauf CL, et al. Among authors: davis fa. Neurology. 1978 Sep;28(9 Pt 2):34-9. doi: 10.1212/wnl.28.9_part_2.34. Neurology. 1978. PMID: 568750 No abstract available.
160 results
Jump to page
Feedback